GPC3 and liver cancer: These results showed that HLC9-EVs could competently transport the encapsulated DNA into the recipient liver cancer cells via HN3-GPC3 mediated targeted delivery and achieve considerable cleavage, which could be considered as effective natural vehicles for CRISPR system.